Published in
Taylor and Francis Group, Leukemia & Lymphoma, 9(61), p. 2122-2128, 2020
DOI: 10.1080/10428194.2020.1755859
Links
Tools
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma
Journal article published in 2020 by
Michele Merli 
,
Irene Defrancesco,
Carlo Visco,
Caroline Besson,
Alice Di Rocco,
Annalisa Arcari,
Antonello Sica,
Emanuele Cencini,
Maria Chiara Tisi,
Marco Frigeni ,
Paolo Grossi,
Benedetta Bianchi,
Barbara Mora,
Lorenza Bertù,
Raffaele Bruno
and other authors.
,
Irene Defrancesco,
Carlo Visco,
Caroline Besson,
Alice Di Rocco,
Annalisa Arcari,
Antonello Sica,
Emanuele Cencini,
Maria Chiara Tisi,
Marco Frigeni ,
Paolo Grossi,
Benedetta Bianchi,
Barbara Mora,
Lorenza Bertù,
Raffaele Bruno
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 